OpenAlex
PricingAboutJobs
Log inGet started
Work

Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy

HTML

Year: 2019
Type: review
Source: Trends in Pharmacological Sciences
DOI: 10.1016/j.tips.2019.11.003
Authors: Yang Liu, Pan Zheng
Institutions: University of Maryland, Baltimore, OncoImmune (United States)
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CTLA-4, immune checkpoint inhibitors, cancer immunotherapy, regulatory T cells, tumor microenvironment, immune-related adverse events, anti-CTLA-4 antibody, immune tolerance, Treg depletion
SDG: Good health and well-being

Open Access status: green

Funders: Melanoma Research Alliance, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Awards: Checkpoints in the cellular response to tissue injury, First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy, A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
OpenAlex ID: W2994949240
FWCI: 1.377
Cites: 68
Cited by: 171
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security